Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Neuromuscular Blocking Agent (NMBA) Revenue

1.5 Market Analysis by Type

1.5.1 Global Neuromuscular Blocking Agent (NMBA) Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Depolarizing

1.5.3 Non-depolarizing

1.6 Market by Application

1.6.1 Global Neuromuscular Blocking Agent (NMBA) Market Share by Application: 2022-2027

1.6.2 Hospital

1.6.3 Clinic

1.6.4 Pharmacy

1.6.5 Others

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Neuromuscular Blocking Agent (NMBA) Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Neuromuscular Blocking Agent (NMBA) Market Players Profiles

3.1 AbbVie

3.1.1 AbbVie Company Profile

3.1.2 AbbVie Neuromuscular Blocking Agent (NMBA) Product Specification

3.1.3 AbbVie Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Somerset Therapeutics

3.2.1 Somerset Therapeutics Company Profile

3.2.2 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Product Specification

3.2.3 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Hengrui Pharmaceutical

3.3.1 Hengrui Pharmaceutical Company Profile

3.3.2 Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product Specification

3.3.3 Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 GlaxoSmithKline

3.4.1 GlaxoSmithKline Company Profile

3.4.2 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Product Specification

3.4.3 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Sandoz

3.5.1 Sandoz Company Profile

3.5.2 Sandoz Neuromuscular Blocking Agent (NMBA) Product Specification

3.5.3 Sandoz Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Pfizer

3.6.1 Pfizer Company Profile

3.6.2 Pfizer Neuromuscular Blocking Agent (NMBA) Product Specification

3.6.3 Pfizer Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Shanghai Pharmaceuticals

3.7.1 Shanghai Pharmaceuticals Company Profile

3.7.2 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Product Specification

3.7.3 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Fresenius Kabi

3.8.1 Fresenius Kabi Company Profile

3.8.2 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Product Specification

3.8.3 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Abbott Laboratories

3.9.1 Abbott Laboratories Company Profile

3.9.2 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Product Specification

3.9.3 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Guike Pharmaceutical

3.10.1 Guike Pharmaceutical Company Profile

3.10.2 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product Specification

3.10.3 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 Themis Medicare

3.11.1 Themis Medicare Company Profile

3.11.2 Themis Medicare Neuromuscular Blocking Agent (NMBA) Product Specification

3.11.3 Themis Medicare Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Nanjing King-Friend

3.12.1 Nanjing King-Friend Company Profile

3.12.2 Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Product Specification

3.12.3 Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Neuromuscular Blocking Agent (NMBA) Market Competition by Market Players

4.1 Global Neuromuscular Blocking Agent (NMBA) Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Market Players (2016-2021)

4.3 Global Neuromuscular Blocking Agent (NMBA) Average Price by Market Players (2016-2021)

5 Global Neuromuscular Blocking Agent (NMBA) Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Neuromuscular Blocking Agent (NMBA) Market Size (2016-2021)

5.1.2 Neuromuscular Blocking Agent (NMBA) Key Players in North America (2016-2021)

5.1.3 North America Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021)

5.1.4 North America Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Neuromuscular Blocking Agent (NMBA) Market Size (2016-2021)

5.2.2 Neuromuscular Blocking Agent (NMBA) Key Players in East Asia (2016-2021)

5.2.3 East Asia Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021)

5.2.4 East Asia Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Neuromuscular Blocking Agent (NMBA) Market Size (2016-2021)

5.3.2 Neuromuscular Blocking Agent (NMBA) Key Players in Europe (2016-2021)

5.3.3 Europe Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021)

5.3.4 Europe Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Neuromuscular Blocking Agent (NMBA) Market Size (2016-2021)

5.4.2 Neuromuscular Blocking Agent (NMBA) Key Players in South Asia (2016-2021)

5.4.3 South Asia Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021)

5.4.4 South Asia Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Neuromuscular Blocking Agent (NMBA) Market Size (2016-2021)

5.5.2 Neuromuscular Blocking Agent (NMBA) Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021)

5.5.4 Southeast Asia Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Neuromuscular Blocking Agent (NMBA) Market Size (2016-2021)

5.6.2 Neuromuscular Blocking Agent (NMBA) Key Players in Middle East (2016-2021)

5.6.3 Middle East Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021)

5.6.4 Middle East Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Neuromuscular Blocking Agent (NMBA) Market Size (2016-2021)

5.7.2 Neuromuscular Blocking Agent (NMBA) Key Players in Africa (2016-2021)

5.7.3 Africa Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021)

5.7.4 Africa Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Neuromuscular Blocking Agent (NMBA) Market Size (2016-2021)

5.8.2 Neuromuscular Blocking Agent (NMBA) Key Players in Oceania (2016-2021)

5.8.3 Oceania Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021)

5.8.4 Oceania Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Neuromuscular Blocking Agent (NMBA) Market Size (2016-2021)

5.9.2 Neuromuscular Blocking Agent (NMBA) Key Players in South America (2016-2021)

5.9.3 South America Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021)

5.9.4 South America Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Neuromuscular Blocking Agent (NMBA) Market Size (2016-2021)

5.10.2 Neuromuscular Blocking Agent (NMBA) Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021)

5.10.4 Rest of the World Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021)

6 Global Neuromuscular Blocking Agent (NMBA) Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Neuromuscular Blocking Agent (NMBA) Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Neuromuscular Blocking Agent (NMBA) Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Neuromuscular Blocking Agent (NMBA) Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Neuromuscular Blocking Agent (NMBA) Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Neuromuscular Blocking Agent (NMBA) Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Neuromuscular Blocking Agent (NMBA) Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Neuromuscular Blocking Agent (NMBA) Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Neuromuscular Blocking Agent (NMBA) Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Neuromuscular Blocking Agent (NMBA) Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Neuromuscular Blocking Agent (NMBA) Consumption by Countries

7 Global Neuromuscular Blocking Agent (NMBA) Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Neuromuscular Blocking Agent (NMBA) (2022-2027)

7.2 Global Forecasted Revenue of Neuromuscular Blocking Agent (NMBA) (2022-2027)

7.3 Global Forecasted Price of Neuromuscular Blocking Agent (NMBA) (2022-2027)

7.4 Global Forecasted Production of Neuromuscular Blocking Agent (NMBA) by Region (2022-2027)

7.4.1 North America Neuromuscular Blocking Agent (NMBA) Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Neuromuscular Blocking Agent (NMBA) Production, Revenue Forecast (2022-2027)

7.4.3 Europe Neuromuscular Blocking Agent (NMBA) Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Neuromuscular Blocking Agent (NMBA) Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Neuromuscular Blocking Agent (NMBA) Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Neuromuscular Blocking Agent (NMBA) Production, Revenue Forecast (2022-2027)

7.4.7 Africa Neuromuscular Blocking Agent (NMBA) Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Neuromuscular Blocking Agent (NMBA) Production, Revenue Forecast (2022-2027)

7.4.9 South America Neuromuscular Blocking Agent (NMBA) Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Neuromuscular Blocking Agent (NMBA) Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Neuromuscular Blocking Agent (NMBA) by Application (2022-2027)

8 Global Neuromuscular Blocking Agent (NMBA) Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Neuromuscular Blocking Agent (NMBA) by Country

8.2 East Asia Market Forecasted Consumption of Neuromuscular Blocking Agent (NMBA) by Country

8.3 Europe Market Forecasted Consumption of Neuromuscular Blocking Agent (NMBA) by Countriy

8.4 South Asia Forecasted Consumption of Neuromuscular Blocking Agent (NMBA) by Country

8.5 Southeast Asia Forecasted Consumption of Neuromuscular Blocking Agent (NMBA) by Country

8.6 Middle East Forecasted Consumption of Neuromuscular Blocking Agent (NMBA) by Country

8.7 Africa Forecasted Consumption of Neuromuscular Blocking Agent (NMBA) by Country

8.8 Oceania Forecasted Consumption of Neuromuscular Blocking Agent (NMBA) by Country

8.9 South America Forecasted Consumption of Neuromuscular Blocking Agent (NMBA) by Country

8.10 Rest of the world Forecasted Consumption of Neuromuscular Blocking Agent (NMBA) by Country

9 Global Neuromuscular Blocking Agent (NMBA) Sales by Type (2016-2027)

9.1 Global Neuromuscular Blocking Agent (NMBA) Historic Market Size by Type (2016-2021)

9.2 Global Neuromuscular Blocking Agent (NMBA) Forecasted Market Size by Type (2022-2027)

10 Global Neuromuscular Blocking Agent (NMBA) Consumption by Application (2016-2027)

10.1 Global Neuromuscular Blocking Agent (NMBA) Historic Market Size by Application (2016-2021)

10.2 Global Neuromuscular Blocking Agent (NMBA) Forecasted Market Size by Application (2022-2027)

11 Global Neuromuscular Blocking Agent (NMBA) Manufacturing Cost Analysis

11.1 Neuromuscular Blocking Agent (NMBA) Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Neuromuscular Blocking Agent (NMBA)

12 Global Neuromuscular Blocking Agent (NMBA) Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Neuromuscular Blocking Agent (NMBA) Distributors List

12.3 Neuromuscular Blocking Agent (NMBA) Customers

12.4 Neuromuscular Blocking Agent (NMBA) Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Neuromuscular Blocking Agent (NMBA) Revenue (US$ Million) 2016-2021

Table 6. Global Neuromuscular Blocking Agent (NMBA) Market Size by Type (US$ Million): 2022-2027

Table 7. Depolarizing Features

Table 8. Non-depolarizing Features

Table 16. Global Neuromuscular Blocking Agent (NMBA) Market Size by Application (US$ Million): 2022-2027

Table 17. Hospital Case Studies

Table 18. Clinic Case Studies

Table 19. Pharmacy Case Studies

Table 20. Others Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Neuromuscular Blocking Agent (NMBA) Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Neuromuscular Blocking Agent (NMBA) Market Growth Strategy

Table 46. Neuromuscular Blocking Agent (NMBA) SWOT Analysis

Table 47. AbbVie Neuromuscular Blocking Agent (NMBA) Product Specification

Table 48. AbbVie Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Product Specification

Table 50. Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product Specification

Table 52. Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Product Specification

Table 54. Table GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Sandoz Neuromuscular Blocking Agent (NMBA) Product Specification

Table 56. Sandoz Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Pfizer Neuromuscular Blocking Agent (NMBA) Product Specification

Table 58. Pfizer Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Product Specification

Table 60. Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Product Specification

Table 62. Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Product Specification

Table 64. Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product Specification

Table 66. Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 67. Themis Medicare Neuromuscular Blocking Agent (NMBA) Product Specification

Table 68. Themis Medicare Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 69. Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Product Specification

Table 70. Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Neuromuscular Blocking Agent (NMBA) Production Capacity by Market Players

Table 148. Global Neuromuscular Blocking Agent (NMBA) Production by Market Players (2016-2021)

Table 149. Global Neuromuscular Blocking Agent (NMBA) Production Market Share by Market Players (2016-2021)

Table 150. Global Neuromuscular Blocking Agent (NMBA) Revenue by Market Players (2016-2021)

Table 151. Global Neuromuscular Blocking Agent (NMBA) Revenue Share by Market Players (2016-2021)

Table 152. Global Market Neuromuscular Blocking Agent (NMBA) Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Neuromuscular Blocking Agent (NMBA) Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Neuromuscular Blocking Agent (NMBA) Market Share (2016-2021)

Table 155. North America Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Neuromuscular Blocking Agent (NMBA) Market Share by Type (2016-2021)

Table 157. North America Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Neuromuscular Blocking Agent (NMBA) Market Share by Application (2016-2021)

Table 159. East Asia Neuromuscular Blocking Agent (NMBA) Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Neuromuscular Blocking Agent (NMBA) Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Neuromuscular Blocking Agent (NMBA) Market Share (2016-2021)

Table 162. East Asia Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Neuromuscular Blocking Agent (NMBA) Market Share by Type (2016-2021)

Table 164. East Asia Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Neuromuscular Blocking Agent (NMBA) Market Share by Application (2016-2021)

Table 166. Europe Neuromuscular Blocking Agent (NMBA) Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Neuromuscular Blocking Agent (NMBA) Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Neuromuscular Blocking Agent (NMBA) Market Share (2016-2021)

Table 169. Europe Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Neuromuscular Blocking Agent (NMBA) Market Share by Type (2016-2021)

Table 171. Europe Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Neuromuscular Blocking Agent (NMBA) Market Share by Application (2016-2021)

Table 173. South Asia Neuromuscular Blocking Agent (NMBA) Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Neuromuscular Blocking Agent (NMBA) Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Neuromuscular Blocking Agent (NMBA) Market Share (2016-2021)

Table 176. South Asia Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Neuromuscular Blocking Agent (NMBA) Market Share by Type (2016-2021)

Table 178. South Asia Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Neuromuscular Blocking Agent (NMBA) Market Share by Application (2016-2021)

Table 180. Southeast Asia Neuromuscular Blocking Agent (NMBA) Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Neuromuscular Blocking Agent (NMBA) Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Neuromuscular Blocking Agent (NMBA) Market Share (2016-2021)

Table 183. Southeast Asia Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Neuromuscular Blocking Agent (NMBA) Market Share by Type (2016-2021)

Table 185. Southeast Asia Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Neuromuscular Blocking Agent (NMBA) Market Share by Application (2016-2021)

Table 187. Middle East Neuromuscular Blocking Agent (NMBA) Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Neuromuscular Blocking Agent (NMBA) Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Neuromuscular Blocking Agent (NMBA) Market Share (2016-2021)

Table 190. Middle East Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Neuromuscular Blocking Agent (NMBA) Market Share by Type (2016-2021)

Table 192. Middle East Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Neuromuscular Blocking Agent (NMBA) Market Share by Application (2016-2021)

Table 194. Africa Neuromuscular Blocking Agent (NMBA) Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Neuromuscular Blocking Agent (NMBA) Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Neuromuscular Blocking Agent (NMBA) Market Share (2016-2021)

Table 197. Africa Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Neuromuscular Blocking Agent (NMBA) Market Share by Type (2016-2021)

Table 199. Africa Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Neuromuscular Blocking Agent (NMBA) Market Share by Application (2016-2021)

Table 201. Oceania Neuromuscular Blocking Agent (NMBA) Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Neuromuscular Blocking Agent (NMBA) Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Neuromuscular Blocking Agent (NMBA) Market Share (2016-2021)

Table 204. Oceania Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Neuromuscular Blocking Agent (NMBA) Market Share by Type (2016-2021)

Table 206. Oceania Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Neuromuscular Blocking Agent (NMBA) Market Share by Application (2016-2021)

Table 208. South America Neuromuscular Blocking Agent (NMBA) Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Neuromuscular Blocking Agent (NMBA) Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Neuromuscular Blocking Agent (NMBA) Market Share (2016-2021)

Table 211. South America Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Neuromuscular Blocking Agent (NMBA) Market Share by Type (2016-2021)

Table 213. South America Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Neuromuscular Blocking Agent (NMBA) Market Share by Application (2016-2021)

Table 215. Rest of the World Neuromuscular Blocking Agent (NMBA) Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Neuromuscular Blocking Agent (NMBA) Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Neuromuscular Blocking Agent (NMBA) Market Share (2016-2021)

Table 218. Rest of the World Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Neuromuscular Blocking Agent (NMBA) Market Share by Type (2016-2021)

Table 220. Rest of the World Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Neuromuscular Blocking Agent (NMBA) Market Share by Application (2016-2021)

Table 222. North America Neuromuscular Blocking Agent (NMBA) Consumption by Countries (2016-2021)

Table 223. East Asia Neuromuscular Blocking Agent (NMBA) Consumption by Countries (2016-2021)

Table 224. Europe Neuromuscular Blocking Agent (NMBA) Consumption by Region (2016-2021)

Table 225. South Asia Neuromuscular Blocking Agent (NMBA) Consumption by Countries (2016-2021)

Table 226. Southeast Asia Neuromuscular Blocking Agent (NMBA) Consumption by Countries (2016-2021)

Table 227. Middle East Neuromuscular Blocking Agent (NMBA) Consumption by Countries (2016-2021)

Table 228. Africa Neuromuscular Blocking Agent (NMBA) Consumption by Countries (2016-2021)

Table 229. Oceania Neuromuscular Blocking Agent (NMBA) Consumption by Countries (2016-2021)

Table 230. South America Neuromuscular Blocking Agent (NMBA) Consumption by Countries (2016-2021)

Table 231. Rest of the World Neuromuscular Blocking Agent (NMBA) Consumption by Countries (2016-2021)

Table 232. Global Neuromuscular Blocking Agent (NMBA) Production Forecast by Region (2022-2027)

Table 233. Global Neuromuscular Blocking Agent (NMBA) Sales Volume Forecast by Type (2022-2027)

Table 234. Global Neuromuscular Blocking Agent (NMBA) Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Neuromuscular Blocking Agent (NMBA) Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Neuromuscular Blocking Agent (NMBA) Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Neuromuscular Blocking Agent (NMBA) Sales Price Forecast by Type (2022-2027)

Table 238. Global Neuromuscular Blocking Agent (NMBA) Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Neuromuscular Blocking Agent (NMBA) Consumption Value Forecast by Application (2022-2027)

Table 240. North America Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027 by Country

Table 241. East Asia Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027 by Country

Table 242. Europe Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027 by Country

Table 243. South Asia Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027 by Country

Table 245. Middle East Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027 by Country

Table 246. Africa Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027 by Country

Table 247. Oceania Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027 by Country

Table 248. South America Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027 by Country

Table 250. Global Neuromuscular Blocking Agent (NMBA) Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Type (2016-2021)

Table 252. Global Neuromuscular Blocking Agent (NMBA) Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Type (2022-2027)

Table 254. Global Neuromuscular Blocking Agent (NMBA) Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Application (2016-2021)

Table 256. Global Neuromuscular Blocking Agent (NMBA) Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Application (2022-2027)

Table 258. Neuromuscular Blocking Agent (NMBA) Distributors List

Table 259. Neuromuscular Blocking Agent (NMBA) Customers List





Figure 1. Product Figure

Figure 2. Global Neuromuscular Blocking Agent (NMBA) Market Share by Type: 2021 VS 2027

Figure 3. Global Neuromuscular Blocking Agent (NMBA) Market Share by Application: 2021 VS 2027

Figure 4. North America Neuromuscular Blocking Agent (NMBA) Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 6. North America Neuromuscular Blocking Agent (NMBA) Consumption Market Share by Countries in 2021

Figure 7. United States Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 8. Canada Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Neuromuscular Blocking Agent (NMBA) Consumption Market Share by Countries in 2021

Figure 12. China Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 13. Japan Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 15. Europe Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate

Figure 16. Europe Neuromuscular Blocking Agent (NMBA) Consumption Market Share by Region in 2021

Figure 17. Germany Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 19. France Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 20. Italy Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 21. Russia Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 22. Spain Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 25. Poland Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate

Figure 27. South Asia Neuromuscular Blocking Agent (NMBA) Consumption Market Share by Countries in 2021

Figure 28. India Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate

Figure 30. Southeast Asia Neuromuscular Blocking Agent (NMBA) Consumption Market Share by Countries in 2021

Figure 31. Indonesia Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate

Figure 37. Middle East Neuromuscular Blocking Agent (NMBA) Consumption Market Share by Countries in 2021

Figure 38. Turkey Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 40. Iran Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 42. Africa Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate

Figure 43. Africa Neuromuscular Blocking Agent (NMBA) Consumption Market Share by Countries in 2021

Figure 44. Nigeria Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate

Figure 47. Oceania Neuromuscular Blocking Agent (NMBA) Consumption Market Share by Countries in 2021

Figure 48. Australia Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 49. South America Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate

Figure 50. South America Neuromuscular Blocking Agent (NMBA) Consumption Market Share by Countries in 2021

Figure 51. Brazil Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate

Figure 54. Rest of the World Neuromuscular Blocking Agent (NMBA) Consumption Market Share by Countries in 2021

Figure 55. Global Neuromuscular Blocking Agent (NMBA) Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Neuromuscular Blocking Agent (NMBA) Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Neuromuscular Blocking Agent (NMBA) Price and Trend Forecast (2022-2027)

Figure 58. North America Neuromuscular Blocking Agent (NMBA) Production Growth Rate Forecast (2022-2027)

Figure 59. North America Neuromuscular Blocking Agent (NMBA) Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Neuromuscular Blocking Agent (NMBA) Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Neuromuscular Blocking Agent (NMBA) Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Neuromuscular Blocking Agent (NMBA) Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Neuromuscular Blocking Agent (NMBA) Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Neuromuscular Blocking Agent (NMBA) Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Neuromuscular Blocking Agent (NMBA) Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Neuromuscular Blocking Agent (NMBA) Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Neuromuscular Blocking Agent (NMBA) Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Neuromuscular Blocking Agent (NMBA) Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Neuromuscular Blocking Agent (NMBA) Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Neuromuscular Blocking Agent (NMBA) Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Neuromuscular Blocking Agent (NMBA) Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Neuromuscular Blocking Agent (NMBA) Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Neuromuscular Blocking Agent (NMBA) Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Neuromuscular Blocking Agent (NMBA) Production Growth Rate Forecast (2022-2027)

Figure 75. South America Neuromuscular Blocking Agent (NMBA) Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Neuromuscular Blocking Agent (NMBA) Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Neuromuscular Blocking Agent (NMBA) Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027

Figure 79. East Asia Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027

Figure 80. Europe Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027

Figure 81. South Asia Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027

Figure 82. Southeast Asia Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027

Figure 83. Middle East Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027

Figure 84. Africa Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027

Figure 85. Oceania Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027

Figure 86. South America Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027

Figure 87. Rest of the world Neuromuscular Blocking Agent (NMBA) Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Neuromuscular Blocking Agent (NMBA)

Figure 89. Manufacturing Process Analysis of Neuromuscular Blocking Agent (NMBA)

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Neuromuscular Blocking Agent (NMBA) Supply Chain Analysis